In a report published Monday, Credit Suisse analyst Daniel Oppenheim initiated coverage on NCI Building Systems NCS with an Outperform rating and $21.00 price target.
In the report, Credit Suisse noted, “NCI will benefit from the recently started recovery in non-residential construction (still just 24% off the bottom and would need a 51% increase to return to normalized levels), with a 100 mln sq ft increase (12% of current levels) translating into $30 mln of EBITDA for NCI. A return to long-term average construction activity would represent incremental EBITDA potential of approximately $130 million plus additional internal initiatives to augment this growth.”
NCI Building Systems closed on Friday at $16.94.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in